Deadly Ebola virus on the brink of being tamed
Preliminary analysis of 499 Ebola infected participants has sprung a surprise — the chances of survival may be as high as 90% if patients are treated with one of the…
Category: Ebola vaccine – rVSV-ZEBOV
Merck’s unlicensed Ebola vaccine shows 97.5% efficacy in Congo
Merck’s Ebola vaccine, which underwent phase-3 trial during the 2014-2015 Ebola epidemic in west Africa, has shown 97.5% efficacy in preventing Ebola disease when used during the current epidemic in…
WHO declares Ebola in Congo as public health emergency
On July 17, the WHO finally declared Ebola virus disease outbreak in Congo a Public Health Emergency of International Concern. Since the beginning of the outbreak in August 2018, Ebola…
Can Congo again swiftly control Ebola spread, death?
Days after the WHO declared the end of the May 8 Ebola outbreak in the Democratic Republic of the Congo, a fresh outbreak was reported on August 1 in North Kivu. If…
Editorial: Victory over Ebola
The alacrity and eagerness shown by the research community to find a safe and efficacious vaccine against the deadly Ebola virus has borne fruit. The interim results of a Phase…
